U.S. Markets closed

Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
17.96-0.17 (-0.94%)
At close: 03:04PM CST

Guangdong Hybribio Biotech Co.,Ltd.

50 Bonham Strand
27th Floor, Strand 50
Sheung Wan
Hong Kong
852 2851 8029

IndustryDiagnostics & Research
Full Time Employees2,356

Key Executives

NameTitlePayExercisedYear Born
Mr. Qiaozhong GuanGM & DirectorN/AN/A1949
Mr. Qinghui LiFin. DirectorN/AN/A1965
Mr. Longxu XieDeputy GM & DirectorN/AN/A1970
Mr. Zhisheng GuanDeputy GM & Non Independent DirectorN/AN/A1984
Ms. Jianyu WangExec. Deputy GM & DirectorN/AN/A1961
Mr. Yi ChenDeputy GM & Board Sec.N/AN/A1979
Xian YuanSecurities RepresentativeN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.


Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. was founded in 2003 and is based in Sheung Wan, Hong Kong.

Corporate Governance

Guangdong Hybribio Biotech Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.